Literature DB >> 25149600

Percutaneous radiofrequency ablation of hepatic tumours: factors affecting technical failure of artificial ascites formation using an angiosheath.

T W Kang1, M W Lee2, M J Hye1, K D Song1, S Lim1, H Rhim1, H K Lim1, D I Cha1.   

Abstract

AIM: To evaluate the technical feasibility of artificial ascites formation using an angiosheath before percutaneous radiofrequency ablation (RFA) for hepatic tumours and to determine predictive factors affecting the technical failure of artificial ascites formation.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board. One hundred and thirteen patients underwent percutaneous RFA of hepatic tumours after trying to make artificial ascites using an angiosheath to avoid collateral thermal damage. The technical success rate of making artificial ascites using an angiosheath and conversion rate to other techniques after initial failure of making artificial ascites were evaluated. The technical success rate for RFA was assessed. In addition, potential factors associated with technical failure including previous history of transcatheter arterial chemoembolization (TACE) or RFA, type of abdominal surgery, and adjacent perihepatic structures were reviewed. Predictive factors for the technical failure of artificial ascites formation were analysed using multivariate analysis.
RESULTS: The technical success rates of artificial ascites formation by angiosheath and that of RFA were 84.1% (95/113) and 97.3% (110/113), respectively. The conversion rate to other techniques after the failure of artificial ascites formation using an angiosheath was 15.9% (18/113). Previous hepatic resection was the sole independent predictive factor affecting the technical failure of artificial ascites formation (p<0.001, odds ratio = 29.03, 95% confidence interval: 4.56-184.69).
CONCLUSION: Making artificial ascites for RFA of hepatic tumours using an angiosheath was technically feasible in most cases. However, history of hepatic resection was a significant predictive factor affecting the technical failure of artificial ascites formation.
Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25149600     DOI: 10.1016/j.crad.2014.07.012

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  10 in total

Review 1.  Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma.

Authors:  Chia-Chi Wang; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2015-06-25       Impact factor: 6.047

Review 2.  Recent Advances in Tumor Ablation for Hepatocellular Carcinoma.

Authors:  Tae Wook Kang; Hyunchul Rhim
Journal:  Liver Cancer       Date:  2015-07-17       Impact factor: 11.740

3.  Artificial ascites using the guidewire technique during microwave ablation in the liver dome: technique and analysis of fluid repartition.

Authors:  Louis Delmas; Guillaume Koch; Roberto Luigi Cazzato; Julia Weiss; Pierre Auloge; Danoob Dalili; Pierre de Marini; Afshin Gangi; Julien Garnon
Journal:  Abdom Radiol (NY)       Date:  2021-04-12

4.  Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Won Sohn; Tae Wook Kang; Sun-Kyu Choi; Sin-Ho Jung; Min Woo Lee; Hyo Keun Lim; Ju-Yeon Cho; Sang Goon Shim; Dong Hyun Sinn; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Hyunchul Rhim; Yong-Han Paik
Journal:  Oncotarget       Date:  2016-07-26

5.  Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.

Authors:  Ju-Yeon Cho; Moon Seok Choi; Gil Sun Lee; Won Sohn; Jemma Ahn; Dong-Hyun Sinn; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  Clin Mol Hepatol       Date:  2016-12-25

6.  Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm).

Authors:  Byung Gon Na; Jong Man Kim; Dong Kyu Oh; Kyo-Won Lee; Tae-Wook Kang; Gyu-Seong Choi; Min Woo Lee; Choon Hyuck David Kwon; Hyun Chul Lim; Jae-Won Joh
Journal:  Ann Surg Treat Res       Date:  2017-04-27       Impact factor: 1.859

7.  Usefulness of Virtual Expiratory CT Images to Compensate for Respiratory Liver Motion in Ultrasound/CT Image Fusion: A Prospective Study in Patients with Focal Hepatic Lesions.

Authors:  Tae Wook Kang; Min Woo Lee; Dong Ik Cha; Hyun Jung Park; Jun Sung Park; Won Chul Bang; Seon Woo Kim
Journal:  Korean J Radiol       Date:  2019-02       Impact factor: 3.500

8.  Efficacy and Safety of Angioplasty Balloon Interposition in CT-Guided Percutaneous Thermal Ablation of Hepatic Malignancies to Protect Adjacent Organs.

Authors:  Michael Schlappa; Wolfgang Wüst; Jürgen Siebler; Robert Grützmann; Michael Uder; Axel Schmid
Journal:  Cardiovasc Intervent Radiol       Date:  2022-07-06       Impact factor: 2.797

Review 9.  Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and Completely.

Authors:  Jin Woong Kim; Sang Soo Shin; Suk Hee Heo; Jun Hyung Hong; Hyo Soon Lim; Hyun Ju Seon; Young Hoe Hur; Chang Hwan Park; Yong Yeon Jeong; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

10.  Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery.

Authors:  Qiannan Huang; Jianguo Li; Qingjing Zeng; Lei Tan; Rongqin Zheng; Xuqi He; Kai Li
Journal:  BMC Cancer       Date:  2020-08-14       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.